Wayne Holman, Ridgeback Capital Like Sangamo Biosciences
Wayne Holman, Ridgeback Capital: Wayne Holman's hedge fund Ridgeback Capital Management recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, Inc.
Sangamo Therapeutics Inc (SGMO)
Market is closed
News
- First
- << Previous
- 31 - 37
Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal the latest moves made by hedge funds and other prominent...
Hedge Funds Are Selling Emergent Biosolutions Inc (EBS)
To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age.
ChemoCentryx Inc (CCXI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
ChemoCentryx Inc (NASDAQ:CCXI) was in 6 hedge funds' portfolio at the end of March. CCXI has experienced an increase in enthusiasm from smart money recently.
Should You Buy Protalix BioTherapeutics Inc. (PLX)?
At the moment, there are many indicators shareholders can use to watch the equity markets. Two of the most innovative are hedge fund and insider trading activity.
Sangamo Biosciences, Inc. (SGMO): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the 21st century investor’s toolkit, there are a multitude of metrics market participants can use to track stocks. A pair of the most under-the-radar are hedge fund and insider trading sentiment.
Sangamo Biosciences, Inc. (SGMO), Tesla Motors Inc (TSLA) & The Never-Ending Comparison
In my portfolio, I hold a small position in a small biotech company by the name of Sangamo Biosciences, Inc. (NASDAQ:SGMO).
- First
- << Previous
- 31 - 37
Billionaire Hedge Funds
